Join
Live feed
·
INSIDERFilingvia Quantisnow
Calidi Biotherapeutics Inc. logo

Director Schoeneck James A was granted 28,207 shares, increasing direct ownership by 3% to 992,094 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CLDI· Calidi Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLDI (Calidi Biotherapeutics Inc.) and more on Quantisnow.